Mike Crawford is Professor of Mental Health Research at Imperial College London and an honorary consultant psychiatrist at Central and North West London NHS Foundation Trust. He is also Director of the Centre for Quality Improvement at the Royal College of Psychiatrists where he oversees the national mental health audit programme.
After completing his medical training at King’s College London he trained in psychiatry at the Royal Free and the Maudsley Hospitals. He completed an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine and an MD on the management of suicidal behaviour at the University of London. In 2004 he worked with colleagues to set up the Waterview Centre, the first specialist service for people with a diagnosis of personality disorder at the Trust. Mike was appointed as an NIHR Senior Investigator in 2019. He is currently working on trials of psychological and pharmacological interventions for people with personality disorder.
Research interest include:
- The evaluation of complex psychosocial interventions for people with severe mental health conditions
- The relationship between the process and outcomes of care delivered to people who have poor mental health
- The development and evaluation of methods for assessing and improving the quality of mental health services
- The role of adjuvant pharmacotherapy for people with severe personality disorder
Crawford M, Huddart D, Craig E et al. (2019) Impact of secondary care financial incentives on the quality of physical health care for people with psychosis. British Journal of Psychiatry doi: 10.1192/bjp.2019.162
Lei H, Barnicot K, Maynard E, Etherington A, Zalewska K, Quirk A, Sanatinia R, Cooper SJ, Crawford MJ. (2019) Factors influencing use of Community Treatment Orders and quality of care that people receive. BJPsych Bulletin 43: 227–235. doi:10.1192/bjb.2019.23
Shastri A, Aimola L, Took B, Quirk A, Corrado O, Crawford MJ (2019) Recognition and treatment of depression in older adults admitted to acute hospitals in England. Clinical Medicine 19: 114–118. doi: 10.7861/clinmedicine.19-2-114
Barnicot K, Crawford MJ (2018) Dialectical behaviour therapy versus mentalization-based therapy for borderline personality disorder. Psychological Medicine 49: 2060-2068. doi.org/10.1017/ S0033291718002878
Crawford MJ, Sanatinia R, Barrett B, et al. (2018) The clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder: A randomized placebo-controlled trial. American Journal of Psychiatry 175:756–764. doi.org/10.1176/appi.ajp.2018.17091006
Further details of his academic work can be found online.